UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 22.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 313,709 shares of the company's stock after acquiring an additional 56,647 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.34% of Acadia Healthcare worth $12,439,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ACHC. JPMorgan Chase & Co. boosted its stake in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after purchasing an additional 454,044 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares during the period. Fifth Third Bancorp grew its holdings in Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after acquiring an additional 454 shares during the period. Blue Trust Inc. raised its position in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after acquiring an additional 345 shares in the last quarter. Finally, KBC Group NV raised its position in shares of Acadia Healthcare by 50.1% in the 4th quarter. KBC Group NV now owns 4,035 shares of the company's stock worth $160,000 after acquiring an additional 1,347 shares in the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC stock traded up $0.81 during trading on Tuesday, hitting $22.44. The company's stock had a trading volume of 1,967,727 shares, compared to its average volume of 1,722,242. The business has a fifty day moving average of $24.78 and a 200-day moving average of $34.04. The company has a market cap of $2.07 billion, a PE ratio of 7.36, a P/E/G ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business's revenue was up .3% compared to the same quarter last year. During the same period last year, the firm posted $0.84 EPS. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Barclays decreased their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 14th. Royal Bank of Canada reduced their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Bank of America dropped their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. Finally, Mizuho cut their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.